Ambrx vs HistoSonics
Ambrx vs HistoSonics, compared side by side on 13 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Ambrx is on 35/100 and HistoSonics on 47/100.
Where each one leads
Ambrx
- funding raised: $462M against $140M
HistoSonics
- our overall score: 47/100 against 35/100
- agent readiness: 37/100 against 22/100
- domain rating: 48/100 against 36/100
At a glance
| Measure | Ambrx | HistoSonics |
|---|---|---|
| What it is | Clinical-stage biopharmaceutical company developing next-generation antibody-drug conjugates (ADCs) for cancer treatment. | Developing a new histotripsy therapeutic platform for cancer treatment. |
| Category | Biotechnology, Drug Discovery, Oncology, Antibody-Drug Conjugates (ADCs) | Biotechnology, Medical Devices, HealthTech, Oncology |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | hardware | services | marketplace | platform | Hardware |
| Founded | 2003 | Not published |
| Headquarters | San Diego, United States | Minneapolis, USA |
| Status | Inactive | Active |
Size, funding and growth
| Measure | Ambrx | HistoSonics |
|---|---|---|
| Total funding | $462M | $140M |
| Latest round | ATM | Funding Round |
| Valuation | Not published | $1.1B |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Ambrx | HistoSonics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 35/100 | 47/100 |
| Traction | 40/100 | 40/100 |
| Team | 70/100 | Not published |
| Community | 12/100 | Not published |
| Search visibility | Not published | 5/100 |
| Quality | 30/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (22/100) | F (37/100) |
| Domain ratingLink authority, 0-100 | 36/100 | 48/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Ambrx | HistoSonics |
|---|---|---|
| CMS | Not detected | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Tag Manager |
| Support stack | Not detected | HubSpot |
What users say
| Measure | Ambrx | HistoSonics |
|---|---|---|
| Reddit sentimentThreads we track | Not published | 4 positive, 0 negative across 6 threads |
“Tumor-destroying soundwaves receive FDA approval for liver treatment in humans. The US FDA has approved HistoSonics to market a liver cancer treatment using histotripsy, an ultrasound-based technology developed at the University of Michigan”r/STEW_ScTecEngWorld
Ambrx vs HistoSonics: common questions
Which is better, Ambrx or HistoSonics?
On our 0-100 score HistoSonics rates higher (47/100 against 35/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 13 data points above: read the rows that match what you are buying for.
How do Ambrx and HistoSonics compare on the numbers?
Ambrx leads on funding raised ($462M against $140M). HistoSonics leads on our overall score (47/100 against 35/100), agent readiness (37/100 against 22/100), domain rating (48/100 against 36/100).
What do real users say about Ambrx and HistoSonics?
HistoSonics: 4 positive and 0 negative mentions across 6 Reddit threads we track, mostly in r/STEW_ScTecEngWorld.
Read the full Ambrx review and pricing or the HistoSonics review and pricing. You can also browse other Ambrx alternatives we track.